Harvard Bioscience Inc (HBIO)
3.60
+0.04
(+1.12%)
USD |
NASDAQ |
Apr 26, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Price to Book Value: 2.138 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.114 |
| April 24, 2024 | 2.192 |
| April 23, 2024 | 2.209 |
| April 22, 2024 | 2.198 |
| April 19, 2024 | 2.198 |
| April 18, 2024 | 2.358 |
| April 17, 2024 | 2.429 |
| April 16, 2024 | 2.482 |
| April 15, 2024 | 2.637 |
| April 12, 2024 | 2.518 |
| April 11, 2024 | 2.580 |
| April 10, 2024 | 2.530 |
| April 09, 2024 | 2.750 |
| April 08, 2024 | 2.560 |
| April 05, 2024 | 2.684 |
| April 04, 2024 | 2.655 |
| April 03, 2024 | 2.494 |
| April 02, 2024 | 2.477 |
| April 01, 2024 | 2.530 |
| March 28, 2024 | 2.518 |
| March 27, 2024 | 2.494 |
| March 26, 2024 | 2.388 |
| March 25, 2024 | 2.453 |
| March 22, 2024 | 2.477 |
| March 21, 2024 | 2.589 |
| Date | Value |
|---|---|
| March 20, 2024 | 2.613 |
| March 19, 2024 | 2.613 |
| March 18, 2024 | 2.465 |
| March 15, 2024 | 2.405 |
| March 14, 2024 | 2.548 |
| March 13, 2024 | 2.607 |
| March 12, 2024 | 2.536 |
| March 11, 2024 | 2.589 |
| March 08, 2024 | 2.625 |
| March 07, 2024 | 2.678 |
| March 06, 2024 | 2.441 |
| March 05, 2024 | 2.488 |
| March 04, 2024 | 2.595 |
| March 01, 2024 | 2.584 |
| February 29, 2024 | 2.571 |
| February 28, 2024 | 2.601 |
| February 27, 2024 | 2.625 |
| February 26, 2024 | 2.595 |
| February 23, 2024 | 2.619 |
| February 22, 2024 | 2.613 |
| February 21, 2024 | 2.637 |
| February 20, 2024 | 2.571 |
| February 16, 2024 | 2.684 |
| February 15, 2024 | 2.886 |
| February 14, 2024 | 2.785 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6666
Minimum
Mar 19 2020
4.387
Maximum
Aug 12 2021
2.283
Average
2.107
Median
Jan 12 2021
Price to Book Value Benchmarks
| Bruker Corp | 8.101 |
| Azenta Inc | 1.191 |
| Bionano Genomics Inc | 0.5005 |
| Akoya Biosciences Inc | 3.482 |
| Singular Genomics Systems Inc | 0.1654 |
Price to Book Value Related Metrics
| PS Ratio | 1.367 |
| Price to Free Cash Flow | 13.09 |
| Price | 3.60 |
| Earnings Yield | -2.22% |
| Market Cap | 156.24M |
| Operating PE Ratio | 81.00 |